BioCentury | Apr 12, 2019
Product Development

NLRP3 early and often

...subsidiary IFM Tre was acquired this month by Novartis AG, is exploring NLRP1, NLRP3, NLRP6, NLRP10...
...domain containing 3 NLRP6 (NALP6) - NLR family pyrin domain containing 6 NLRP10 (NALP10) - NLR family pyrin domain containing 10...
...173 Allison Johnson, Staff Writer IFM Therapeutics LLC Inflazome Ltd. Nodthera Ltd. Novartis AG Roche NLR family pyrin domain containing 1 (NLRP1) (NALP1) NLR family pyrin domain containing 10 (NLRP10) (NALP10) NLR...
BioCentury | Sep 14, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: August 2017

...disease (IBD); hyperuricemia / gout; non-alcoholic steatohepatitis (NASH) NLR family pyrin domain containing 10 (NLRP10; NALP10) Small molecule inhibitors of NLRP10...
BioCentury | Aug 11, 2017
Strategy

The flip-side of immunotherapy

...processes. Other members of the family pursued by IFM include NLRP1 , NLRP3, NLRP6 , NLRP10...
...domain containing 3 NLRP6 (NALP6) - NLR family pyrin domain containing 6 NLRP10 (NALP10) - NLR family pyrin domain containing 10...
Items per page:
1 - 3 of 3